Selected article for: "cytokine storm and present study"
Author: Spuch, Carlos; López-García, Marta; Rivera-Baltanás, Tania; Rodrígues-Amorím, Daniela; Olivares, José M.
Title: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
  • Cord-id: 7ye3nu3a
  • Document date: 2020_8_27
    • ID: 7ye3nu3a
    Snippet: Lithium has shown the capacity to: a) inhibit the replication of several types of viruses, some of which are similar to the SARS-CoV-2 virus, b) increase the immune response by reducing lymphopenia, and c) reduce inflammation by preventing or reducing the cytokine storm. In the present study, we have treated six patients with severe COVID-19 infection with lithium carbonate. We found that lithium carbonate significantly reduced plasma reactive C-Protein levels, increased lymphocyte numbers and d
    Document: Lithium has shown the capacity to: a) inhibit the replication of several types of viruses, some of which are similar to the SARS-CoV-2 virus, b) increase the immune response by reducing lymphopenia, and c) reduce inflammation by preventing or reducing the cytokine storm. In the present study, we have treated six patients with severe COVID-19 infection with lithium carbonate. We found that lithium carbonate significantly reduced plasma reactive C-Protein levels, increased lymphocyte numbers and decreased the neutrophil-lymphocyte ratio, improving both inflammatory activity and the immune response in these patients. We propose that lithium carbonate may deserve a place in the treatment against COVID-19.

    Search related documents:
    Co phrase search for related documents
    • lopinavir hydroxychloroquine and lymphocyte count: 1, 2
    • lopinavir ritonavir and low middle: 1, 2, 3
    • lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lopinavir ritonavir hydroxychloroquine and lymphocyte count: 1, 2
    • lopinavir ritonavir hydroxychloroquine treatment and lymphocyte count: 1, 2
    • lopinavir ritonavir treatment and lymphocyte count: 1, 2, 3, 4
    • low middle and lymphocyte count: 1, 2
    • lung basis and lymphocyte count: 1